Lauri H Suominen

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Genomatica, Inc., Aquafil S.p.a., Oxford Finance LLC. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lauri H Suominen. Retrieved from https://idiyas.com/inventor/lauri-h-suominen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503711 - METHOD OF PRODUCING & PROCESSING DIAMINES TO A DIAMINE FREE BASE USING A CARBONATE INTERMEDIATE AND AN ENGINEERED MICROORGANISM (2025-12-23),

2. 12043859 - Recovery, decarboxylation, and purification of cannabinoids from engineered cell cultures (2024-07-23),

3. 11753372 - Process for the production of epsilon caprolactam from 6-aminocaproic acid (2023-09-12),

4. 11702682 - Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism (2023-07-18),

5. 10711289 - Method of producing and processing diamines from an engineered microorganism (2020-07-14),

Title: Lauri H Suominen: Innovator in Cannabinoid Recovery and Nylon Production

Introduction

Lauri H Suominen is a notable inventor based in San Diego, CA, with a focus on innovative methods for cannabinoid recovery and the production of epsilon caprolactam. With a total of 5 patents to his name, Suominen has made significant contributions to both biochemical and industrial processes.

Latest Patents

Suominen's latest patents include groundbreaking methods for the recovery, decarboxylation, and purification of cannabinoids from engineered cell cultures. These methods involve separating the cell culture at varying temperatures to isolate cannabinoids in different phases. Additionally, he has developed processes that utilize both water-miscible and water-immiscible solvents to enhance cannabinoid recovery. Another significant patent focuses on a new process for producing epsilon caprolactam from 6-aminocaproic acid, which promises shorter reaction times and energy savings, making it advantageous for industrial-scale production.

Career Highlights

Throughout his career, Lauri H Suominen has worked with prominent companies such as Genomatica, Inc. and Aquafil S.p.a. His innovative approaches have positioned him as a leader in the field of biochemical engineering and industrial applications.

Collaborations

Suominen has collaborated with talented individuals, including Michael Japs and Connor J Galleher, contributing to the advancement of his research and innovations.

Conclusion

Lauri H Suominen's work exemplifies the intersection of innovation and practical application in the fields of cannabinoid recovery and nylon production. His contributions continue to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.